←Back to structures
CAKLQF020000010.1__CAH1085058.1__SAMEA5780031_02153__00098
Bact-VirCAKLQF020000010.1__CAH1085058.1__SAMEA5780031_02153__00098
3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
medium
residues 86-163
Domain cluster:
representative
Pfam (1)
| Accession | Name | Score | E-value | Q cov | HMM cov |
|---|---|---|---|---|---|
| PF00866.25 best | Ring_hydroxyl_B | 46.5 | 5.60e-12 | 91.0% | 49.3% |
CATH (74)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 2ckfB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.91 | 86.0 | 6.47e-01 | 100.0% | 48.2% |
| 3e99A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.91 | 84.0 | 6.53e-01 | 100.0% | 50.7% |
| 2b1xB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.91 | 86.0 | 6.50e-01 | 100.0% | 48.5% |
| 1uliB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.91 | 86.0 | 6.35e-01 | 100.0% | 46.3% |
| 5bkaE01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.86 | 68.0 | 5.62e-01 | 83.3% | 53.8% |
| 3robA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.85 | 69.0 | 5.68e-01 | 85.9% | 52.7% |
| 3ef8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.84 | 75.0 | 5.94e-01 | 94.9% | 51.4% |
| 1tp6A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.84 | 66.0 | 5.47e-01 | 84.6% | 50.8% |
| 5ig0A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.84 | 66.0 | 5.46e-01 | 83.3% | 52.7% |
| 3soyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.83 | 67.0 | 5.39e-01 | 85.9% | 50.7% |
| 3ub1D02 | 3.10.450.540 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.83 | 60.0 | 5.21e-01 | 80.8% | 51.8% |
| 4l8oA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.82 | 70.0 | 5.40e-01 | 91.0% | 47.6% |
| 3b7cA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.82 | 63.0 | 5.31e-01 | 82.1% | 51.7% |
| 3q90B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.82 | 63.0 | 5.21e-01 | 87.2% | 48.5% |
| 1ar0A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.82 | 64.0 | 5.42e-01 | 87.2% | 52.0% |
| 3b8lA01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.81 | 72.0 | 5.82e-01 | 96.2% | 55.3% |
| 3ebyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.81 | 74.0 | 5.85e-01 | 100.0% | 51.6% |
| 3a76A01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.80 | 68.0 | 5.48e-01 | 89.7% | 52.5% |
| 3hzpA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.80 | 65.0 | 5.43e-01 | 85.9% | 55.1% |
| 2f86B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.80 | 62.0 | 5.17e-01 | 82.1% | 51.9% |
| 2bngC00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.80 | 62.0 | 5.01e-01 | 91.0% | 45.7% |
| 3h51A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.79 | 65.0 | 5.24e-01 | 87.2% | 48.6% |
| 3eyrA00 | 3.15.10.40 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › Uncharacterised protein PF07273 family, DUF1439 | 0.79 | 72.0 | 5.52e-01 | 100.0% | 54.4% |
| 1wnhA02 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.79 | 59.0 | 5.10e-01 | 85.9% | 51.7% |
| 3d9rB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.78 | 62.0 | 5.19e-01 | 85.9% | 52.6% |
| 1of5A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.78 | 62.0 | 4.95e-01 | 85.9% | 49.4% |
| 7f13A01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.78 | 67.0 | 5.38e-01 | 94.9% | 50.0% |
| 3fsdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.78 | 62.0 | 5.30e-01 | 84.6% | 57.0% |
| 3kspA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.78 | 62.0 | 5.16e-01 | 84.6% | 51.2% |
| 3mg1B02 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.77 | 59.0 | 4.98e-01 | 84.6% | 50.4% |
| 7c5yA02 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.77 | 58.0 | 4.62e-01 | 80.8% | 85.6% |
| 2r4iA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.76 | 61.0 | 5.16e-01 | 84.6% | 53.7% |
| 4j8tA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.76 | 63.0 | 5.31e-01 | 89.7% | 55.5% |
| 1vqqA01 | 3.10.450.100 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › NTF2-like; domain 1 | 0.76 | 58.0 | 5.13e-01 | 100.0% | 57.8% |
| 3dmcA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.75 | 59.0 | 4.87e-01 | 85.9% | 48.5% |
| 1bp1A01 | 3.15.10.10 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › Bactericidal permeability-increasing protein; domain 1 | 0.75 | 67.0 | 5.13e-01 | 100.0% | 78.9% |
| 4o3vA00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.75 | 63.0 | 5.10e-01 | 89.7% | 55.8% |
| 1s5aB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.74 | 66.0 | 5.27e-01 | 94.9% | 52.4% |
| 3h4zB03 | 3.15.10.50 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › | 0.74 | 67.0 | 5.00e-01 | 100.0% | 73.3% |
| 1nu3A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.74 | 62.0 | 5.09e-01 | 96.2% | 50.3% |
| 3ec9A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 61.0 | 5.12e-01 | 92.3% | 54.3% |
| 3grdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 62.0 | 5.16e-01 | 92.3% | 54.5% |
| 3k0zA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 59.0 | 4.71e-01 | 92.3% | 45.6% |
| 2rckA01 | 3.15.10.30 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › TULIP domain | 0.72 | 64.0 | 4.67e-01 | 100.0% | 63.3% |
| 4h3uA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 61.0 | 5.16e-01 | 94.9% | 58.5% |
| 3dm8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 59.0 | 4.90e-01 | 91.0% | 54.1% |
| 3hk4A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 51.0 | 4.43e-01 | 78.2% | 50.0% |
| 3bb9B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 54.0 | 4.61e-01 | 82.1% | 52.0% |
| 1v1qA00 | 2.40.50.140 | Mainly Beta › Beta Barrel › OB fold (Dihydrolipoamide Acetyltransferase, E2P) › Nucleic acid-binding proteins | 0.70 | 49.0 | 4.35e-01 | 73.1% | 77.3% |
| 3fgyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 61.0 | 5.06e-01 | 97.4% | 68.9% |
| 4ec6A00 | 3.10.450.540 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 53.0 | 4.74e-01 | 83.3% | 80.7% |
| 2owpA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 52.0 | 4.40e-01 | 85.9% | 49.6% |
| 2i9wA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 49.0 | 3.76e-01 | 79.5% | 35.8% |
| 2gtlN02 | 2.40.128.620 | Mainly Beta › Beta Barrel › Lipocalin › | 0.64 | 56.0 | 4.36e-01 | 97.4% | 60.6% |
| 2lyxA00 | 3.10.450.390 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › Protein of unknown function DUF3889 | 0.64 | 45.0 | 4.35e-01 | 85.9% | 66.7% |
| 3en2A00 | 2.40.50.140 | Mainly Beta › Beta Barrel › OB fold (Dihydrolipoamide Acetyltransferase, E2P) › Nucleic acid-binding proteins | 0.63 | 46.0 | 4.36e-01 | 76.9% | 84.6% |
| 3atsA01 | 3.30.200.20 | Alpha Beta › 2-Layer Sandwich › Phosphorylase Kinase; domain 1 › Phosphorylase Kinase; domain 1 | 0.62 | 49.0 | 4.28e-01 | 84.6% | 87.1% |
| 6x05A01 | 2.130.10.10 | Mainly Beta › 7 Propeller › Methylamine Dehydrogenase; Chain H › YVTN repeat-like/Quinoprotein amine dehydrogenase | 0.62 | 45.0 | 2.97e-01 | 87.2% | 16.4% |
| 1t17A00 | 3.30.530.20 | Alpha Beta › 2-Layer Sandwich › Alpha-D-Glucose-1,6-Bisphosphate; Chain A, domain 4 › START domain | 0.62 | 52.0 | 4.30e-01 | 96.2% | 67.6% |
| 1ut7B01 | 2.170.150.80 | Mainly Beta › Beta Complex › Metal Binding Protein, Guanine Nucleotide Exchange Factor; Chain A › NAC domain | 0.61 | 47.0 | 4.07e-01 | 84.6% | 75.2% |
| 1hq0A00 | 3.60.100.10 | Alpha Beta › 4-Layer Sandwich › Cytotoxic necrotizing factor 1 (CNF1) › Cytotoxic necrotizing factor, Rho-activating domain | 0.61 | 46.0 | 3.22e-01 | 84.6% | 96.3% |
| 2gtlO02 | 2.40.128.620 | Mainly Beta › Beta Barrel › Lipocalin › | 0.60 | 52.0 | 4.15e-01 | 97.4% | 61.3% |
| 2cwaA01 | 2.40.50.140 | Mainly Beta › Beta Barrel › OB fold (Dihydrolipoamide Acetyltransferase, E2P) › Nucleic acid-binding proteins | 0.60 | 43.0 | 3.88e-01 | 75.6% | 68.8% |
| 3n72A00 | 3.15.10.20 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › Activator of Hsp90 ATPase Aha1, N-terminal domain | 0.60 | 53.0 | 4.37e-01 | 100.0% | 63.6% |
| 1se8A02 | 2.40.50.140 | Mainly Beta › Beta Barrel › OB fold (Dihydrolipoamide Acetyltransferase, E2P) › Nucleic acid-binding proteins | 0.56 | 41.0 | 3.71e-01 | 78.2% | 73.9% |
| 1ex2A00 | 3.90.950.10 | Alpha Beta › Alpha-Beta Complex › Maf protein › | 0.55 | 45.0 | 3.50e-01 | 93.6% | 94.1% |
| 7a0hA02 | 3.90.1150.210 | Alpha Beta › Alpha-Beta Complex › Aspartate Aminotransferase, domain 1 › F-actin capping protein, beta subunit | 0.55 | 47.0 | 3.63e-01 | 94.9% | 76.4% |
| 1qftB00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.54 | 46.0 | 3.63e-01 | 96.2% | 51.5% |
| 4jhcB00 | 3.90.950.10 | Alpha Beta › Alpha-Beta Complex › Maf protein › | 0.54 | 44.0 | 3.47e-01 | 93.6% | 94.0% |
| 4rt0A00 | 2.40.10.220 | Mainly Beta › Beta Barrel › Thrombin, subunit H › predicted glycosyltransferase like domains | 0.53 | 44.0 | 4.06e-01 | 97.4% | 86.2% |
| 5da9A01 | 3.40.50.300 | Alpha Beta › 3-Layer(aba) Sandwich › Rossmann fold › P-loop containing nucleotide triphosphate hydrolases | 0.53 | 37.0 | 2.44e-01 | 73.1% | 16.4% |
| 1b7eA01 | 3.90.350.10 | Alpha Beta › Alpha-Beta Complex › Transposase Inhibitor Protein From Tn5; Chain A, domain 1 › Transposase Inhibitor Protein From Tn5; Chain A, domain 1 | 0.52 | 37.0 | 2.71e-01 | 75.6% | 32.9% |
| 1lhpA00 | 3.40.1190.20 | Alpha Beta › 3-Layer(aba) Sandwich › UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase › Ribokinase | 0.51 | 38.0 | 2.65e-01 | 83.3% | 65.7% |
| 2nlkA02 | 3.90.190.10 | Alpha Beta › Alpha-Beta Complex › Protein-Tyrosine Phosphatase; Chain A › Protein tyrosine phosphatase superfamily | 0.50 | 38.0 | 2.78e-01 | 85.9% | 29.2% |
ECOD (91)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 4676601 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.93 | 88.0 | 6.61e-01 | 100.0% | 46.2% |
| 163051 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.91 | 86.0 | 6.47e-01 | 100.0% | 48.2% |
| 4884000 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.91 | 86.0 | 6.59e-01 | 100.0% | 51.9% |
| 3970009 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.90 | 85.0 | 6.36e-01 | 100.0% | 46.7% |
| 4283272 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.89 | 84.0 | 6.28e-01 | 100.0% | 46.5% |
| 5009713 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.88 | 78.0 | 5.98e-01 | 93.6% | 46.3% |
| 4950139 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.86 | 70.0 | 5.86e-01 | 85.9% | 53.6% |
| 1674783 | 243.1.1.15 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › T4BSS_DotI_IcmL | 0.86 | 69.0 | 5.55e-01 | 84.6% | 79.9% |
| 3941713 | 243.1.1.6 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › VirB8 | 0.86 | 66.0 | 5.31e-01 | 80.8% | 56.4% |
| 2628859 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.86 | 70.0 | 5.69e-01 | 85.9% | 56.0% |
| 5059048 | 243.1.1.13 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › CaMKII_AD | 0.85 | 68.0 | 5.75e-01 | 84.6% | 54.5% |
| 3958251 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.85 | 66.0 | 5.17e-01 | 82.1% | 42.9% |
| 3056323 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.85 | 78.0 | 6.09e-01 | 100.0% | 50.6% |
| 4254866 | 243.1.1.66 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TcaA_5th | 0.84 | 64.0 | 5.37e-01 | 79.5% | 51.2% |
| 6408 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.84 | 75.0 | 5.92e-01 | 94.9% | 51.0% |
| 4016448 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.84 | 71.0 | 5.65e-01 | 89.7% | 51.0% |
| 4152363 | 243.1.1.115 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29733 | 0.84 | 67.0 | 5.65e-01 | 84.6% | 53.7% |
| 3727055 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.83 | 71.0 | 5.62e-01 | 89.7% | 52.4% |
| 3957821 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.83 | 65.0 | 5.39e-01 | 82.1% | 80.5% |
| 3281242 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.83 | 71.0 | 5.82e-01 | 89.7% | 55.4% |
| 1558628 | 243.1.1.15 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › T4BSS_DotI_IcmL | 0.83 | 66.0 | 5.36e-01 | 84.6% | 82.1% |
| 2632043 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.83 | 67.0 | 5.44e-01 | 85.9% | 52.1% |
| 3970236 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.82 | 68.0 | 5.48e-01 | 87.2% | 51.8% |
| 3291726 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.82 | 63.0 | 4.95e-01 | 80.8% | 44.8% |
| 3962739 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.82 | 63.0 | 4.99e-01 | 80.8% | 46.0% |
| 399927 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.82 | 68.0 | 5.35e-01 | 88.5% | 47.7% |
| 4315252 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.82 | 68.0 | 5.44e-01 | 88.5% | 50.3% |
| 5003871 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.82 | 68.0 | 5.51e-01 | 88.5% | 50.0% |
| 3963115 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.82 | 63.0 | 5.02e-01 | 80.8% | 44.8% |
| 5022156 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.82 | 67.0 | 5.44e-01 | 87.2% | 50.0% |
| 3959534 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.82 | 62.0 | 5.12e-01 | 80.8% | 48.1% |
| 3698353 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.81 | 63.0 | 5.31e-01 | 82.1% | 52.8% |
| 3808862 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.81 | 66.0 | 5.34e-01 | 85.9% | 50.7% |
| 3952458 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.81 | 63.0 | 5.26e-01 | 83.3% | 50.8% |
| 4472109 | 243.1.1.103 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF30257 | 0.80 | 64.0 | 5.46e-01 | 84.6% | 55.0% |
| 135548 | 243.1.1.19 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF3804 | 0.80 | 65.0 | 5.41e-01 | 85.9% | 54.7% |
| 3710733 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.80 | 62.0 | 5.30e-01 | 84.6% | 53.3% |
| 3731745 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.80 | 66.0 | 5.13e-01 | 88.5% | 47.5% |
| 3262201 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.79 | 71.0 | 5.68e-01 | 96.2% | 53.8% |
| 3801133 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.79 | 63.0 | 5.27e-01 | 84.6% | 51.6% |
| 137905 | 883.1.1.5 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › DUF1439 | 0.79 | 72.0 | 5.51e-01 | 100.0% | 53.8% |
| 3725005 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.79 | 68.0 | 5.62e-01 | 93.6% | 54.8% |
| 3733248 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.79 | 69.0 | 5.36e-01 | 94.9% | 50.0% |
| 4020443 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.78 | 62.0 | 5.29e-01 | 85.9% | 53.7% |
| 3588474 | 243.1.1.17 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TpcC | 0.78 | 61.0 | 5.26e-01 | 83.3% | 83.3% |
| 3278986 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.78 | 61.0 | 4.82e-01 | 83.3% | 45.8% |
| 3296374 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.78 | 60.0 | 4.65e-01 | 85.9% | 38.8% |
| 170212 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.78 | 62.0 | 5.30e-01 | 84.6% | 57.0% |
| 137634 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.78 | 62.0 | 5.16e-01 | 84.6% | 51.2% |
| 6405 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.78 | 63.0 | 5.23e-01 | 87.2% | 53.0% |
| 3307679 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.78 | 62.0 | 5.08e-01 | 87.2% | 47.9% |
| 4074364 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.78 | 60.0 | 5.01e-01 | 85.9% | 49.2% |
| 3459974 | 243.1.1.45 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › S6PP_C | 0.77 | 71.0 | 5.54e-01 | 100.0% | 50.3% |
| 3288890 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.77 | 57.0 | 4.79e-01 | 78.2% | 76.9% |
| 3959285 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.77 | 58.0 | 5.73e-01 | 80.8% | 82.1% |
| 3453643 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.77 | 62.0 | 4.97e-01 | 87.2% | 46.2% |
| 4193401 | 243.1.1.34 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › YchJ_M-like | 0.77 | 59.0 | 5.26e-01 | 85.9% | 58.2% |
| 3545097 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.76 | 68.0 | 5.13e-01 | 100.0% | 63.2% |
| 3517998 | 243.1.1.40 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NXF_NTF2 | 0.76 | 61.0 | 4.47e-01 | 85.9% | 73.0% |
| 3958382 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.75 | 62.0 | 5.14e-01 | 93.6% | 51.9% |
| 3734807 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.75 | 66.0 | 5.03e-01 | 94.9% | 44.7% |
| 4561192 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.75 | 59.0 | 5.88e-01 | 96.2% | 81.2% |
| 3818687 | 243.1.1.49 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF2358 | 0.75 | 63.0 | 5.12e-01 | 92.3% | 60.7% |
| 3278323 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.74 | 60.0 | 5.00e-01 | 85.9% | 52.3% |
| 3804281 | 243.1.1.45 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › S6PP_C | 0.74 | 67.0 | 5.50e-01 | 100.0% | 56.5% |
| 3289158 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.72 | 53.0 | 4.74e-01 | 82.1% | 55.5% |
| 3591282 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.72 | 56.0 | 4.83e-01 | 84.6% | 54.6% |
| 4865157 | 243.1.1.17 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TpcC | 0.72 | 56.0 | 4.88e-01 | 83.3% | 80.2% |
| 3660552 | 243.3.1.12 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › SQAPI | 0.71 | 54.0 | 4.93e-01 | 83.3% | 63.0% |
| 3425790 | 243.3.1.19 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › DUF3615 | 0.70 | 56.0 | 5.30e-01 | 87.2% | 75.8% |
| 2722108 | 243.1.1.67 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Cds6_C | 0.70 | 51.0 | 4.41e-01 | 80.8% | 49.2% |
| 3466996 | 243.3.1.19 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › DUF3615 | 0.69 | 53.0 | 4.60e-01 | 82.1% | 71.7% |
| 3433417 | 243.3.1.19 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › DUF3615 | 0.68 | 52.0 | 4.77e-01 | 87.2% | 61.9% |
| 3246578 | 5.1.4.1 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed › WD40 | 0.68 | 51.0 | 3.25e-01 | 84.6% | 15.7% |
| 4445572 | 4099.1.1.22 ↗ | a+b two layers › Kinetochore globular domain-like › Kinetochore globular domain-like › Kinetochore globular domain-like › CENP-P | 0.68 | 60.0 | 5.03e-01 | 97.4% | 76.2% |
| 3395729 | 331.3.1.0 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like | 0.67 | 58.0 | 4.54e-01 | 94.9% | 71.2% |
| 4254174 | 4099.1.1.22 ↗ | a+b two layers › Kinetochore globular domain-like › Kinetochore globular domain-like › Kinetochore globular domain-like › CENP-P | 0.66 | 58.0 | 4.72e-01 | 97.4% | 62.8% |
| 3372143 | 881.1.1.1 ↗ | a+b three layers › Mog1p/PsbP-like › Mog1p/PsbP-like › Mog1p/PsbP-like › PsbP | 0.65 | 51.0 | 4.42e-01 | 85.9% | 64.0% |
| 2765234 | 243.3.1.12 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › SQAPI | 0.64 | 50.0 | 4.71e-01 | 85.9% | 69.1% |
| 3297404 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.63 | 50.0 | 4.18e-01 | 87.2% | 50.7% |
| 4304377 | 243.1.1.12 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TIM21 | 0.63 | 53.0 | 4.84e-01 | 96.2% | 80.0% |
| 3182613 | 243.1.1.44 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › MBA1 | 0.60 | 45.0 | 3.40e-01 | 84.6% | 33.2% |
| 3744012 | 5.1.4.16 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed › CPSF_A | 0.60 | 47.0 | 3.07e-01 | 85.9% | 26.9% |
| 3512269 | 79.1.1.16 ↗ | beta duplicates or obligate multimers › Phage tail fiber protein trimerization domain › Phage tail fiber protein trimerization domain › Phage tail fiber protein trimerization domain › DUF1983 | 0.59 | 48.0 | 4.61e-01 | 89.7% | 76.7% |
| 2769983 | 3692.1.1.1 ↗ | a+b two layers › Ornithine cyclodeaminase-like enzymes dimerization domain › Ornithine cyclodeaminase-like enzymes dimerization domain › Ornithine cyclodeaminase-like enzymes dimerization domain › OCD_Mu_crystall | 0.59 | 51.0 | 4.29e-01 | 98.7% | 67.9% |
| 3697493 | 5.1.5.70 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 8-bladed › TFIIIC_delta | 0.59 | 46.0 | 2.96e-01 | 89.7% | 17.0% |
| 4039776 | 243.3.1.48 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › GlfB_C | 0.58 | 47.0 | 3.88e-01 | 96.2% | 53.1% |
| 3749122 | 5.1.3.176 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 6-bladed › APEH_N | 0.56 | 48.0 | 3.09e-01 | 98.7% | 98.8% |
| 4966638 | 881.1.1.44 ↗ | a+b three layers › Mog1p/PsbP-like › Mog1p/PsbP-like › Mog1p/PsbP-like › DUF6517 | 0.53 | 43.0 | 3.30e-01 | 91.0% | 57.9% |
| 3056279 | 4051.1.1.2 ↗ | a+b two layers › a+b domain in Capz › a+b domain in Capz › a+b domain in Capz › F-actin_cap_A | 0.52 | 44.0 | 3.47e-01 | 93.6% | 66.3% |
| 3971813 | 5084.8.1.0 ↗ | beta barrels › Outer membrane meander beta-barrels › Usher PapC translocation pore › Usher PapC translocation pore | 0.52 | 42.0 | 2.69e-01 | 92.3% | 18.6% |